Key takeaways
- Muscle loss is real: Up to 25–40% of weight lost on GLP-1 medications can come from lean mass without exercise
- Resistance training is essential: Strength training at least twice per week is the most effective way to preserve muscle
- Protein intake matters: Aim for 1.2–1.6 g of protein per kilogram of body weight daily
- Timing helps: Schedule workouts away from injection day to minimise nausea-related interference
- NHS guidance supports it: NICE recommends combining GLP-1 therapy with structured behavioural programmes including physical activity
Why exercise is critical on GLP-1 medications
GLP-1 receptor agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide) produce significant weight loss by reducing appetite and slowing gastric emptying. However, this rapid calorie reduction creates a challenge: the body does not exclusively burn fat. Without adequate physical activity, a substantial portion of the weight lost comes from skeletal muscle and bone mineral density.
Data from the STEP 1 trial showed that participants who lost an average of 14.9 per cent of their body weight on semaglutide 2.4 mg experienced lean mass losses of approximately 39 per cent of total weight lost. The SURMOUNT-1 trial for tirzepatide reported broadly similar proportions. These figures underscore why exercise is not merely beneficial but essential when taking GLP-1 medications.
NICE guidance for both semaglutide and tirzepatide stipulates that treatment should be delivered alongside a structured programme of dietary change and physical activity. This is not an afterthought — it is a core component of the treatment pathway.
The muscle loss problem explained
When the body is in a sustained calorie deficit, it does not selectively target fat stores. Muscle protein is broken down for energy alongside adipose tissue. This process, known as lean mass catabolism, is accelerated by several factors common in GLP-1 treatment:
- Reduced appetite: Lower calorie and protein intake means less raw material for muscle repair
- Rapid weight loss: Faster weight loss correlates with greater lean mass loss
- Reduced physical activity: Nausea and fatigue during dose escalation may discourage exercise
- Age: Patients over 50 are already experiencing sarcopenia (age-related muscle decline)
The clinical significance is real. Loss of muscle mass reduces metabolic rate, impairs functional capacity, increases fall risk (particularly in older adults) and may contribute to weight regain after treatment discontinuation. This is why preserving lean mass should be a primary goal during GLP-1 therapy.
Strength training: the most important exercise type
Resistance training is the single most effective intervention for preventing muscle loss during weight loss. Multiple studies have demonstrated that structured strength training can reduce lean mass losses by 50 per cent or more compared with calorie restriction alone.
What counts as resistance training?
- Free weights: Dumbbells, barbells, kettlebells
- Machine weights: Available in most UK gyms and leisure centres
- Bodyweight exercises: Press-ups, squats, lunges, planks, pull-ups
- Resistance bands: Affordable and effective for home workouts
How much strength training do you need?
Current UK Chief Medical Officer guidelines recommend muscle-strengthening activities on at least two days per week for all adults. For people on GLP-1 medications, this should be considered the absolute minimum. A practical target is two to four resistance sessions per week, focusing on compound movements that work multiple large muscle groups:
- Lower body: Squats, leg press, Romanian deadlifts, lunges
- Upper body: Bench press, overhead press, rows, lat pull-downs
- Core: Planks, dead bugs, Pallof press
Practical tip: If you are new to strength training, many local authority leisure centres and NHS-commissioned programmes offer guided sessions. Second Nature, an NHS-commissioned weight management provider, includes exercise guidance as part of their GLP-1 programmes.
Cardio: still important, but not the priority
Cardiovascular exercise remains valuable for heart health, mental wellbeing and overall fitness. However, when time is limited, strength training should take precedence for people on GLP-1 medications because cardio alone does little to prevent muscle loss.
Recommended cardio approach
- Moderate-intensity: Brisk walking, cycling, swimming — 150 minutes per week (NHS guideline)
- Vigorous-intensity: Running, HIIT, rowing — 75 minutes per week as an alternative
- Daily movement: Walking 7,000–10,000 steps per day supports overall health and energy expenditure
Evidence note: A 2024 systematic review published in Obesity Reviews concluded that combining resistance training with moderate cardio during GLP-1 therapy produced the best outcomes for body composition — maximising fat loss whilst preserving lean mass.
Strength vs cardio: a practical comparison
| Factor | Strength training | Cardio |
|---|---|---|
| Muscle preservation | Excellent — primary benefit | Minimal effect |
| Fat loss | Moderate (raises resting metabolic rate) | Good (burns calories during activity) |
| Cardiovascular health | Moderate benefit | Excellent |
| Bone density | Excellent — weight-bearing loads | Moderate (weight-bearing types only) |
| Mental health | Strong evidence | Strong evidence |
| Time efficiency | 30–45 min per session | 20–60 min per session |
| Equipment needed | Some (or bodyweight) | None (walking/running) |
When to train: timing around your injection
GLP-1 medications are administered once weekly, and many patients experience a peak in side effects — particularly nausea, fatigue and reduced appetite — in the 24 to 48 hours following injection. Planning your exercise schedule around this pattern can improve adherence and performance.
Suggested weekly schedule
- Injection day: Rest day or very light activity (gentle walk)
- Day after injection: Light activity if nausea is manageable; otherwise rest
- Days 3–7: Schedule your main training sessions during this window when side effects are typically lowest
This is a general guideline. Individual responses vary considerably. Some patients experience minimal side effects and can train on injection day without difficulty. Others may need the full 48-hour window. Adjust based on your own experience.
Protein: the dietary cornerstone
Exercise alone is not sufficient to preserve muscle mass during a calorie deficit. Adequate protein intake is equally important. Current evidence suggests people taking GLP-1 medications should aim for:
- Minimum: 1.2 g of protein per kilogram of body weight per day
- Optimal: 1.4–1.6 g per kilogram per day, especially if strength training regularly
- Distribution: Spread intake across 3–4 meals, aiming for 25–40 g per serving
This can be challenging when appetite is significantly reduced. Practical strategies include prioritising protein at every meal, consuming protein-rich foods first before other macronutrients, and using supplemental protein shakes if whole-food intake is insufficient.
Important: People with kidney disease should consult their GP or renal dietitian before increasing protein intake. Higher protein diets are not appropriate for everyone.
A sample weekly exercise plan
This template is designed for someone taking a weekly GLP-1 injection on Sunday evening. Adjust the injection day to match your own schedule.
| Day | Activity | Duration |
|---|---|---|
| Monday | Rest or light walk (post-injection) | 20–30 min |
| Tuesday | Upper body strength training | 35–45 min |
| Wednesday | Moderate cardio (brisk walk, cycle or swim) | 30–45 min |
| Thursday | Lower body strength training | 35–45 min |
| Friday | Rest or light activity | — |
| Saturday | Full body strength or HIIT session | 30–40 min |
| Sunday | Injection day — gentle walk if tolerated | 20 min |
Monitoring progress beyond the scales
When combining GLP-1 medication with resistance training, body weight alone is a poor measure of progress. Muscle is denser than fat, so body recomposition — losing fat whilst gaining or preserving muscle — may not register dramatically on the scales. More informative metrics include:
- Waist circumference: A reliable indicator of visceral fat loss
- Strength gains: Tracking weights lifted over time
- Body composition scans: DEXA scans (available privately in the UK from approximately £100–£150) provide precise fat and lean mass measurements
- Functional capacity: Ability to perform daily tasks, climb stairs, carry shopping
- How clothing fits: Often the most noticeable early indicator
Frequently asked questions
Can I exercise on the day of my injection?
Yes, there is no medical contraindication to exercising on injection day. However, many patients find that nausea and fatigue are more pronounced in the 24 hours after injection, which may affect workout quality. Most people find it easier to train on days 3 to 6 after injection.
Will exercise slow down my weight loss?
Exercise, particularly strength training, may cause a temporary plateau on the scales because you are building muscle whilst losing fat. This is a positive outcome. Your body composition improves even if total weight changes more slowly. Focus on waist circumference and how you feel rather than the number on the scales.
I feel too nauseous to exercise. What should I do?
Nausea is common during dose escalation. On difficult days, opt for gentle walking rather than forcing an intense session. If nausea persists beyond the escalation phase, discuss this with your prescriber as it may indicate that a dose adjustment is needed. For more on managing side effects, see our GLP-1 side effects guide.
Do I need a personal trainer?
A personal trainer is not essential but can be very helpful if you are new to resistance training. Many UK gyms offer an introductory session when you join. NHS-commissioned weight management programmes such as Second Nature include exercise guidance as part of the package.